Device Trial Radar · NCT02812784
Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?
Last checked: Nov 19, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
184
Actual
Start
Sep 16, 2015
Primary completion
Feb 11, 2019
Study completion Feb 11, 2019
Sponsor
- Lead sponsor
- Centre Hospitalier Universitaire, AmiensAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 24, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Patients with septic shock in the intensive care unit have an elevated risk of developing acute kidney injury (AKI).
Conditions
- Heading
Interventions
Nephrocheck TMDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- KDIGO classificationTime frame: 72 hours
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
CHU Amiens
Amiens, France
CH Avranches-Granville
Avranches, France
CH Cahors
Cahors, France
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.